Literature DB >> 17180094

The ICE family of cysteine proteases as effectors of cell death.

S Kumar1, M F Lavin.   

Abstract

Programmed cellular suicide follows a set of distinct morphological events involving profound cytoplasmic and nuclear changes. The recent discovery of a family of mammalian homologues of the Caenorhabditis elegans cell death protein CED-3 is now providing insight into how these events might be brought about. These mammalian proteins encode cysteine proteases with homology to the interleukin-1beta converting enzyme (ICE). CED-3 and seven of its currently known mammalian homologues cleave their substrates after an aspartate residue, a property shared only by the cytotoxic T cell (CTL) protease granzyme B which is necessary for the CTL-mediated killing of target cells. A number of proteins previously known to be cleaved in cells undergoing apoptosis have now been shown to be targeted by ICE-like proteases. Although many questions remain, it is becoming increasingly clear that this unique group of proteases play a central effector role in the process of physiological cell death. This article reviews various aspects of the ICE family of proteases.

Entities:  

Year:  1996        PMID: 17180094

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  20 in total

1.  Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Signaling of neuronal cell death by the p75NTR neurotrophin receptor.

Authors:  E J Coulson; K Reid; P F Bartlett
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

3.  A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis.

Authors:  S Kagaya; C Kitanaka; K Noguchi; T Mochizuki; A Sugiyama; A Asai; N Yasuhara; Y Eguchi; Y Tsujimoto; Y Kuchino
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.

Authors:  S Oliverio; A Amendola; F Di Sano; M G Farrace; L Fesus; Z Nemes; L Piredda; A Spinedi; M Piacentini
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 5.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

6.  Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2.

Authors:  D Grandgirard; E Studer; L Monney; T Belser; I Fellay; C Borner; M R Michel
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

7.  Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.

Authors:  Y Cheng; M Deshmukh; A D'Costa; J A Demaro; J M Gidday; A Shah; Y Sun; M F Jacquin; E M Johnson; D M Holtzman
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

8.  JTE-522-induced apoptosis in human gastric adenocarcinoma [correction of adenocarcinoma] cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of mitochondrial membrane potential.

Authors:  Hong-Liang Li; Dan-Dan Chen; Xiao-Hong Li; Hai-Wei Zhang; Jun-Hua Lü; Xian-Da Ren; Cun-Chuan Wang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

9.  Peptide targeting of platinum anti-cancer drugs.

Authors:  Margaret W Ndinguri; Rajasree Solipuram; Robert P Gambrell; Sita Aggarwal; Robert P Hammer
Journal:  Bioconjug Chem       Date:  2009-09-23       Impact factor: 4.774

10.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.